Clal Biotechnology reported ILS158.39M in Assets for its fiscal quarter ending in December of 2023.





Assets Change Date
aTyr Pharma USD 106.65M 5.12M Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 97.84M 8.68M Sep/2025
RedHill Biopharma USD 18.38M 332K Jun/2025